期刊文献+

猪牙皂正丁醇提取物含药血清抑制人肝癌细胞SMMC-7721的实验研究 被引量:8

Inhibitory effects of medicated serum of gleditsia sinensis Lam n-butanol extract on human hepatoma cell SMMC-7721
暂未订购
导出
摘要 目的:研究猪牙皂提取物正丁醇部位对人肝癌细胞SMMC-7721的抑制效应。方法:40只Wistar雄性大鼠分为4组,其中1组给予生理盐水,其余3组分别给予高、中、低剂量猪牙皂正丁醇提取物(0.6g·kg-1·d-1、0.3g·kg-1·d-1、0.15g·kg-1·d-1)灌喂3天,采集其含药血清作用于人肝癌SMMC-7721细胞,MTT法检测细胞抑制率。结果:猪牙皂正丁醇提取物中、低剂量明显抑制人肝癌SMMC-7721细胞,高剂量无明显效果。结论:猪牙皂正丁醇提取物能够抑制人肝癌SMMC-7721细胞。 Objective: To study the inhibitory effect of butanol extract of gleditsia sinensis Lam. on human hepatoma cell line SMMC-7721. Methods: Forty Wistar male rats were divided into four groups, one group was given normal saline gastrogavage as a control group and other three groups were given respectively by high (0. 6g·kg^-1·d^-1 ), middle (0. 3g·kg^-1·d^-1 ), and low (0. 15g·kg^-1·d^-1 ) dosage of butanol extract of gleditsia for three days, then collecting medicated serum to affect on human hepatoma cell line SMMC-7721. Inhibition ratio was calculated by MTF essay. Results: There were significantly on middle and low doses of butanol extract of gleditsia inhibited human hepatoma cell SMMC-7721, but no significant in high dosage group. Conclusion: Butanol extract of gleditsia can suppress human hepatoma cell line SMMC-7721.
出处 《中西医结合肝病杂志》 CAS 2013年第5期279-281,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金 中国中医科学院新药创制联合课题(2011XYCZ-13)
关键词 猪牙皂 皂荚 正丁醇 提取物 含药血清 药效基团 SMMC-7721细胞 抑制率 gleditsia sinensis Lam butanol extract medicated serum pharmacophore SMMC-7721 cells inhibition rate
  • 相关文献

参考文献9

二级参考文献41

  • 1王庆才.生南星生半夏在肿瘤临床中的应用[J].辽宁中医杂志,1993,20(3):37-38. 被引量:25
  • 2鞠立霞,陈喆,任荣政.活血化瘀中药治疗原发性肝癌研究进展[J].中西医结合学报,2005,3(6):491-494. 被引量:16
  • 3杨宗辉,尹建元,魏征人,颜炜群.天南星提取物诱导人肝癌SMMC-7721细胞凋亡及其机制的实验研究[J].中国老年学杂志,2007,27(2):142-144. 被引量:37
  • 4香港理工大学.中药皂荚浓缩液具有抗癌特性.山东中医药大学学报,2005,31(4):286-286.
  • 5KIYONO K, SUZUKI HI, MATSUYAMA H. et al. Autophagy is activated by TGF - beta and potentiates TGF - beta - mediated growth inhibition in human hepatocelluler carcinoma cells [J] . Cancer Res, 2009, 69 (23): 52.
  • 6SUBRAMANIAN G, SCHWARZ R E, HIGGINS L et al. Targeting endogenous transforming growth factor beta receptor signaLing in SMAIM deficient pancreatic carcinoma cells inhibits their invaaive phenotypel [J] . Cancer Res, 2004, 64 (15) : 5200 -5211.
  • 7SHI Y, Structural insights on Smad function in TGF beta signaLing [J] .Bioessays, 2001, 23 (3): 223-232.
  • 8Pils D, Wittinger M, Petz M, et al. BAMB is overexpressed in ovarian cancer and co - translocates with Smads into the nucleus upon TGF -ss treatment [J] . Gynecol Oncol, 2010, 117 (2) : 189 -97.
  • 9KAISER C, MEURICE N, GONZALES IM, et al. Chemogenomic analysis identifies Macbecin Ⅱ as a compound specific for SMAD4 - negative colon cancer cells [J] . Chem Biol Drug Des, 2010, 75 (4) : 360 - 8.
  • 10TORBENSON M, MARINOPOUL OS S, DAND DT, et al. Smad 4 overexpression in hepato cell carcinoma is strongLy associatedwith transforming growth factor beta II receptor immunolabeling [J] . Hum Pathol, 2004, 33 (9): 871-876.

共引文献1670

同被引文献125

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部